Ocugen (OCGN) Notes Payables (2018 - 2021)
Ocugen (OCGN) reported Notes Payables of $374000.0 for Q1 2021, up 59.83% quarter-over-quarter from $234000.0 in Q4 2020.
Ocugen (OCGN) Notes Payables (2018 - 2021) Analysis & Trends
Ocugen has reported Notes Payables for 4 years, with the latest figure at $374000.0 in Q1 2021.
- For the quarter ending Q1 2021, Notes Payables changed N/A year-over-year to $374000.0; the trailing twelve-month figure through Mar 2021 stood at $374000.0 (changed N/A YoY), and the FY2020 full-year result was $234000.0, changed N/A from the prior year.
- Notes Payables for Q1 2021 stood at $374000.0, up from $234000.0 in the prior quarter.
- The five-year high for Notes Payables was $7.5 million in Q4 2018, with the low at $234000.0 in Q4 2020.
- Historically, Notes Payables has averaged $3.0 million across 4 years, with a median of $2.6 million in 2020.
- The largest YoY upside for Notes Payables was 6.94% in 2020 against a maximum downside of 6.94% in 2020.
- Ocugen's Notes Payables stood at $7.5 million in 2018, then slumped by 41.59% to $4.4 million in 2019, then slumped by 94.65% to $234000.0 in 2020, then surged by 59.83% to $374000.0 in 2021.
- The last three Notes Payables figures came in at $374000.0 (Q1 2021), $234000.0 (Q4 2020), and $1.2 million (Q3 2020), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Ocugen | 411.07 Mn | 411.07 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 374,000.00 |
| Dec 31, 2020 | 234,000.00 |
| Sep 30, 2020 | 1.21 Mn |
| Jun 30, 2020 | 4.07 Mn |
| Jun 30, 2019 | 4.37 Mn |
| Dec 31, 2018 | 7.48 Mn |